Skip to main content
Signal8
McKee Kelly T. Jr. profile photo

Kelly T. McKee Jr.

CIK: 0001903889

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GeoVax Labs, Inc. logo
GOVX

GeoVax Labs, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • GeoVax Labs, Inc. logo
    GOVX

    GeoVax Labs, Inc.

    Jun 17, 2026
    Award(A)

    Stock Option

    Direct
    17.6K shares-
  • GeoVax Labs, Inc. logo
    GOVX

    GeoVax Labs, Inc.

    Aug 7, 2025
    Purchase(P)
    Direct
    1.1K shares at avg. $0.67$741.69
  • GeoVax Labs, Inc. logo
    GOVX

    GeoVax Labs, Inc.

    Jun 5, 2025
    Award(A)

    Stock Option

    Direct
    70K shares-

1-3 of 3

About McKee Kelly T. Jr.

McKee Kelly T. Jr. (SEC CIK 0001903889) files insider reports with the SEC as Chief Medical Officer of GeoVax Labs, Inc. (GOVX).

Signal8 holds 3 ownership filings by McKee Kelly T. Jr., all Form 4s, filed between Jun 6, 2025 and Jun 22, 2026. Those filings report 3 transactions, from Jun 5, 2025 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on McKee Kelly T. Jr.'s filings is in SMYRNA, GA.

Recent filings by McKee Kelly T. Jr.

  • Jun 17, 2026: Grant or award of GOVX derivative securities (Form 4, code A).
  • Aug 7, 2025: Open-market purchase of GOVX shares (Form 4, code P).
  • Jun 5, 2025: Grant or award of GOVX derivative securities (Form 4, code A).

Other insiders filing for GeoVax Labs, Inc. (GOVX)

How to read Form 4 transaction codes